Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION (Poster 2)
Monday, May 1, 2023
1:00 PM – 2:30 PM ET
Location: Convention Center: 206
Publication Number: 3380.4
Leonard B. Bacharier, Vanderbilt University Medical Center, Nashville, TN, United States; Jorge F.. Maspero, Fundacion Cidea, Buenos Aires, Buenos Aires, Argentina; Constance H. Katelaris, Campbelltown hospital and western sydney university, Sydney, New South Wales, Australia; Alessandro G. Fiocchi, Ospedale Pediatrico Bambino Gesù, Cassano d'Adda, Lombardia, Italy; Rémi Gagnon, Clinique Spécialisée en Allergie de la Capitale (CSAC), Quebec, PQ, Canada; Ines De Mir Messa, University Hospital Vall d'Hebron, Barcelona, Catalonia, Spain; Theresa W. Guilbert, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Daniel J. Jackson, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States; Nicholas M. Jellots, Sanofi-Genzyme, Indiana, PA, United States; Ning Li, Sanofi, Beijing, Beijing, China (People's Republic); Bolanle Akinlade, Regeneron, Tarrytown, NY, United States; Elizabeth Laws, Sanofi, Lawrenceville, NJ, United States; Leda P. Mannent, sanofi, Paris, Ile-de-France, France; Jennifer Maloney, Regeneron, Tarrytown, NY, United States; Kelsey Tawo, Sanofi, Bridgewater, NJ, United States; Faisal A. Khokhar, Regeneron, Tarrytown, NY, United States; Megan Hardin, Sanofi, Cambridge, MA, United States; Raolat M. Abdulai, Sanofi, Washington, DC, United States; David J. Lederer, Regeneron Pharmaceuticals, Tarrytown, NY, United States; Lacey B. Robinson, Sanofi, Cambridge, MA, United States
Presenting Author(s)
Nicholas M. Jellots, PharmD, BCPS (he/him/his)
Medical Science Liaison Sanofi Indiana, Pennsylvania, United States
Disclosure(s):
Leonard Bacharier, MD: AstraZeneca (Ongoing) (Products/Services: Board Member or Executive Role, Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness); Cystic Fibrosis Foundation (Ongoing) (Products/Services: Board Member or Executive Role); DBV Technologies (Ongoing) (Products/Services: Board Member or Executive Role); GSK (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); NIH (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); OMPharma (Ongoing) (Products/Services: Consultant); Regeneron Pharmaceuticals, Inc. (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness)
jorge F. maspero, MD, FCCP, FAAAAI: AstraZeneca (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); GSK (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Immunotek (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Menarini (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Novartis (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Uriach (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness)
Constance H. Katelaris, MD PhD: Sanofi (Terminated, December 19, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness)
Alessandro Fiocchi, Director: Abbott (Ongoing) (Products/Services: Advisory Committee); Danone (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); DBV Technologies (Ongoing) (Products/Services: Advisory Committee); Ferrero (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); HiPP Organic (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Novartis (Ongoing) (Products/Services: Advisory Committee); Sanofi (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Stallergenes Greer (Ongoing) (Products/Services: Advisory Committee)
Rémi Gagnon, MD, MSc: ALK (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); AstraZeneca (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Bausch & Lomb (Ongoing) (Products/Services: Advisory Committee); BioCryst (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); DBV Technologies (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Novartis (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Regeneron Pharmaceuticals, Inc. (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Sanofi (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Takeda (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Ines De Mir Messa, MD, PhD: GSK (Ongoing) (Products/Services: Board Member or Executive Role, Speaker Honorarium including speakers bureau, symposia, and expert witness); Novartis (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Board Member or Executive Role, Speaker Honorarium including speakers bureau, symposia, and expert witness)
Theresa W. Guilbert, MD, MS: AICME (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Amgen (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); AstraZeneca (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Genetech (Terminated, December 31, 2022) (Products/Services: Advisory Committee); GSK (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); OM Pharma (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Polarean (Terminated, December 31, 2021) (Products/Services: Advisory Committee); Regeneron (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); Sanofi (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness); UpToDate (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties)
Daniel J. jackson, MD: AstraZeneca (Ongoing) (Products/Services: Advisory Committee); Avillion (Ongoing) (Products/Services: Advisory Committee); GlaxoSmithKline (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Pfizer (Terminated, October 1, 2022) (Products/Services: Consultant); Regeneron (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Sanofi (Ongoing) (Products/Services: Consultant)
Nicholas M. Jellots, PharmD, BCPS: Sanofi (Ongoing) (Products/Services: Employment with an ineligible company, Employment with an ineligible company)
Ning Li, Master of science: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Bolanle Akinlade, MD: Regeneron Pharmaceuticals (Ongoing) (Products/Services: Employment with an ineligible company)
Elizabeth Laws, PhD: Sanofi (Ongoing) (Products/Services: Employment with an ineligible company)
Leda Mannent, MD: sanofi (Ongoing) (Products/Services: Employment with an ineligible company)
Jennifer Maloney, MD: Regeneron (Ongoing) (Products/Services: Employment with an ineligible company)
Kelsey Tawo, MD: sanofi (Ongoing) (Products/Services: Employment with an ineligible company)
Faisal A. Khokhar, MD: Regeneron (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Megan Hardin, MD, MPH: Sanofi (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Raolat M. Abdulai, Medical Doctorate: Sanofi (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
David J. Lederer, MD, MS: Regeneron Pharmaceuticals (Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Lacey B. Robinson, MD, MPH: Sanofi (Ongoing) (Products/Services: Employment with an ineligible company)
